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The activity of PGLa, an antimicrobial peptide isolated from hemocytes of frog skin and its secretions on living Escherichia coli, was
investigated by imaging the cells with atomic force microscopy (AFM) in physiological conditions and by measuring its cellular stiffness. The
treatment of bacteria with the antimicrobial peptide PGLa in the culture medium had two stages. The first was characterized by the loss of
surface stiffness and consequent loss of bacteria topographic features and the formation of micelles probably originating from the disruption of
the outer membrane. The formation of outer membrane originated micelles is in agreement with the carpet-like mechanism of action proposed
for antimicrobial peptides of the magainin family. The peptide action also resulted in the removal of bacterial pili. In a second stage there was
further damage which resulted in total cell rupture. The addition of Mg2 + ions prior to peptide treatment partially inhibited the effects of PGLa
on bacteria. This result suggests that PGLa interacts with the outer membrane by displacing Mg2 + from LPS, inserting itself into the bilayer
and cross-bridging the negative charges of LPS lipids as proposed in the self-promoted pathway mechanism. The peptide effect on the bacteria
was compared to the activity of the chelating agent EDTA that damages the bacterial outer membrane by removing Mg2 + ions.
D 2003 Elsevier B.V. All rights reserved.Keywords: Escherichia coli; Antimicrobial peptide PGLa; EDTA; Cellular stiffness; Structural cellular variation1. Introduction
Organisms throughout the phylogenetic tree, including
animals [1], produce substances for protection against
microbes. Many of these substances are peptides. Natural
antimicrobial peptides participate in the innate immune
systems of most multicellular organisms. Because of the
growing problem of pathogenic organisms, which are resis-
tant to conventional antibiotics, there is increased interest in
the pharmacological application of antimicrobial peptides to
treat infection. Efforts are currently underway to increase the
potency and specificity of these peptides so that they become
toxic to microbes and not to mammals. In order to achieve
this in an efficient manner, it is important to understand the
mechanism of action of these agents and the reason for their
selectivity against microbes [2–5].
In general, the mechanism of action of antimicrobial
peptides is not very well established. For many of these
peptides, there is evidence that one of the targets for the
peptide is the lipid bilayer of the membrane. In addition, most0167-4889/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamcr.2003.10.001
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E-mail address: oteschke@ifi.unicamp.br (O. Teschke).of the antimicrobial peptides are cationic and their interac-
tion with anionic phospholipids would provide a ready
explanation for their specificity for bacterial membranes. In
gram-negative bacteria, both the outer leaflet of the plasma
membrane as well as the outer membrane contain anionic
molecules oriented towards the exterior of the cell. This is
not the case for mammalian membranes. There is uncertain-
ty, however, about how these peptides perturb the membrane
and whether this membrane perturbation is related to the
antimicrobial activity of these peptides. It has recently been
shown that there is not always a correlation between the
ability of peptides to permeabilize membranes and their
antimicrobial activity [6]. It is possible that the membrane
effects of these peptides are not directly related to their
mechanism of cytotoxic action but rather simply the manner
by which they enter the cell to reach an alternative target [6].
In the present work the bactericidal effect of the antimi-
crobial peptide PGLa upon Escherichia coli is analyzed in
vivo through atomic force microscopy (AFM) both in
physiological medium and in air. For imaging in the phys-
iological medium the preparation of the bacterial sample
involved only a quick air-drying step followed by rehydra-
tion in culture medium. When dried in ambient conditions
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when returned to liquid [7]. This approach allows the direct
observation of processes occurring in the surface of living
bacteria, which may be suitable for the analysis of the
activity of antimicrobial peptides in situ.2. Experimental
2.1. Antimicrobial peptide PGLa
In the present work the bactericidal effect of the antimi-
crobial peptide PGLa, a 21-residue peptide with an amidated
carboxy terminus (GMASKAGAIAGKIAKVALKAK), a
member of the magainin family of antibiotic peptides found
in frog skin and its secretions [8] upon E. coli, is analyzed in
vivo through AFM both in the physiological medium and in
air. The use of AFM allowed the direct observation of
processes occurring in the surface of living bacteria treated
with the antimicrobial peptide. The effects of the antimicro-
bial peptide are compared to the activity of ethylenediami-
netetraacetic acid (EDTA), a chelating agent that interferes
with the outer membrane of E. coli [9].
2.2. Bacteria
The most famous and well-studied rod-shaped bacterium
E. coli (363, Pasteur Institute) was chosen for the experi-
ment. Bacteria were cultured till mid-log stage on a LB
medium (Bacto Triptone 10 g, Bacto Yeast Extract 5 g, NaCl
5 g/l, pH 7.0) at 37 jC with vigorous shaking. The concen-
tration of 109–1010 cfu/ml was used for AFM experiments.
2.3. Sample preparation
For AFM imaging in liquid, mica was pretreated with
polylysine for immobilization of bacteria [10]. A 10-Al drop
of 10 2 M polylysine solution (SIGMA, poly-L-lysine,
437,000 Da) was applied to a freshly cleaved mica surface
and air-dried. A 5–10-Al drop of bacteria suspension was
applied onto the treated mica. After drying in ambient (25
jC, 60% humidity) conditions, the culture medium LB was
injected into the fluid cell [7]. Polylysine is readily adsorbed
by mica and remains in stochastic globule conformation at
pH under 12.0 [11]. Under these conditions, the polylysine
gives mica a smooth, positively charged coverage in the form
of tightly packed globules with average lateral dimension of
20 nm (data not shown). Such coverage is inappropriate for
imaging individual macromolecules, but is smooth enough
(RMS roughness 1.5 nm) for imaging ‘‘huge’’ objects like
bacteria. Our experiments indicated that bacteria showed
much better adhesion to the mica surface covered with
polylysine than on freshly cleaved mica (data not shown).
For imaging in air, the samples were prepared by simply
depositing 5 Al from suspensions of control and peptide
treated bacteria on the mica surface. After drying, thesample was rinsed with deionized water for removal of salt
crystals.
2.4. AFM analysis
AFM experiments in the contact mode of operation were
carried out using a TopoMetrix TMX2000 scanning probe
microscope (SPM). Nanoprobe cantilevers made of silicon
nitride (Si3N4) (Microleverk, type B, ThermoMicroscopes)
with a spring constant of k = 0.03 N/m were used both in the
liquid and air. The radius of curvature of the AFM tip is
approximately 5 nm. The topographic images of the surface
as well as the force-distance over the sample surface were
registered. During the force vs. distance measurements, the
tip/substrate approach speed in z-direction was varied from
0.1 to 100 Am/s. Each map of the sample surface consisted of
300 300 grid points.
The force vs. distance curves presented were registered
using at least five different positions at the upper part of the
bacteria with the various approach velocities. The best
signal-to-noise ratio curves were used. In order to verify
the cell stiffness in both conditions, the stiffness of the
bacteria in solution was measured in the presence and
absence of PGLa.
Many assumptions have been made for an accurate
determination of the elastic modulus of live bacteria in
culture medium. The bacterium, which is assumed to be
isotropic, smooth and elastic, is, however, anisotropic and
rough. The uncertainty of the contact area and a small lateral
component in the applied force due to the approach with a
small angle are usually ignored and influence the accuracy of
the measurement. Very often, only a comparison between
two different states is needed [12]. The acquisition of elastic
data without a detailed characterization of the parameters
described above is relevant in the case described here.
The root-mean-square (rms) roughness of the bacteria
surface imaged in air is calculated by using the AFM Region
Analysis Mode. The rms roughness Rrms is defined by
the expression Rrms ¼
PN
n¼1ðzn  z¯Þ2=n 1 where z¯ is the
mean height z. The calculated rms roughness refers only
to the area shown in the inset of figures.3. Results
3.1. Adhesion of bacteria cells to substrate
The samples prepared by drying on bare mica resulted in a
bacteria deposit loosely attached to the substrate and most
cells were swept away during contact scanning (data not
shown). Since the mica surface is negatively charged in
liquid, poor adhesion could be explained by the electrostatic
repulsion between the substrate and the negatively charged
surface of bacteria.
Fig. 1a illustrates the typical image of an isolated E. coli
bacteria attached to a mica surface covered with polylysine
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under favorable conditions to bacteria since the images
remained stable during repetitive scanning of the area.
The vertical profile of the displayed image shows that the
width of the observed E. coli bacterium is f 2.4 Am and its
height is f 1.0 Am; however, bacteria were observed witha large variation in both width and length. The maximum
sized bacterium had a length off 7.7 Am and a width of
f 2.2 Am.
3.2. PGLa action
Fig. 1b shows an AFM image of bacteria 5 min after the
addition of PGLa (10 AM). The bacteria under the action of
PGLa show the formation of micelles indicated by arrows.
By comparing Fig. 1a and b, we observe that a conforma-
tional alteration from rod-shaped bacteria to a fluid flattened
structure occurred. Under these conditions, images had lower
resolution probably due to the deformation of bacteria during
scanning. Fig. 1c shows images of bacteria 30 min after the
addition of PGLa (10 AM) where only the lower part of the
cellular membrane is left attached to the substrate. The
measured profile lines show that the residual structure has
widths and lengths that correspond to the size of the bacteria
previously fixed to the substrate.
3.3. PGLa reduces bacteria rigidity (determination of
vertical tip-cell interaction force in liquid)
Fig. 2 displays force vs. distance average curves, at five
selected locations of the cell’s upper surface for untreated
bacteria (control, curve x), bacteria treated with EDTA (10
mM) (curve 5) and bacteria treated with PGLa (10 AM)
(curve 4). At long distances, D>400 nm, the force is
constant. The strong repulsive force (starting at A or C) is
due to the deformation of the bacteria body from its equi-
librium configuration when in contact with the tip. The
cantilever deflection increases as the tip continues to press
into the sample after contact, as represented by the section of
the force curve AB (or CB) in Fig. 2 (curve5). The slope of
the AB (or CB) section of the force curve represents the
surface stiffness [13]. The stiffness of the bacteria can be
simply calculated from the slope of the measured force to the
left of point A (or C) in Fig. 2; assuming that the bacteria and
cantilever act as two springs in series, the measured bacteria




where kcant is the cantilever spring constant, x (see Fig. 2) is
the cantilever deflection when pushed against the bacteriaFig. 1. (a) E. coli observed on mica covered with polylysine in physiological
solution. The AFM image of the bacterium profile showed a height off 1
Am and a length off 4.1 Am. Since the observed bacteria are in distinct
stages of development, various bacteria sizes have been measured and the
maximum sized bacterium observed showed a length off 7.7 Am and a
height off 2.2 Am (scanned area 4.2 4.2 Am2). (b) PGLa action on E. coli
bacteria deposited on a polylysine covered mica surface 5 min after the
addition of PGLa (10 AM). Arrows indicate the position of adhered micelles
(scanned area 5 5 Am2). (c) Images of bacteria, 30 min after the addition of
PGLa (10 AM), which show only the lower part of the outer membrane after
cell lysis (scanned area 8 8 Am2).
Fig. 2. Force vs. distances curves measured on the central part of the bacteria and averaged five times. The control curve (x) was measured on the top of
untreated bacteria in physiological solutions. The curve indicated by4 was measured on the top of the bacteria 5 min after the addition of PGLa (10 AM) to the
physiological solution. Observe that the slope for displacement larger than the indicated by C shows a decrease when compared to the one measured on the
untreated bacteria. Effect of EDTA (20 mM) 5 min after addition (shown by 5). Untreated bacteria curve error barf 5%.
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curve slope. Since the substrate displacement is the sum of
the tip displacement plus the decrease in the sample width,
Dz is always greater than Dx and Dz/Dx is always larger
than 1.
In the above expression, bacteria stiffness was compared
to the stiffness of the cantilever. The cantilever stiffness was
calibrated using the procedure of Sander [14] and also mica/
water interfaces were probed where the force gradient is
larger than the cantilever spring constant. An instability was
registered; the slope of the linear part of force curve
measured in these regions gave the spring constant value.
Since in this work we are interested in changes in the
stiffness of cells induced by some biological agent, only
relative values of stiffness were required and control experi-
ments were not performed. The proposed method compares
the stiffness of very soft cantilevers kf 0.03 N/m with the
sample stiffness. Hard substrates as mica show very large
stiffness and this method is not adequate. On the other hand,
soft substrates such as cells show a stiffness of up to 100
greater than the one of the cantilever and can be easily
measured by this method. The resolution of the method is
associated with the measurement of the slope of the tip
displacement (force/cantilever spring constant) vs. the sep-
aration curve. The standard procedure is to plot force in
Newton vs. separation in meters. We chose to divide the
vertical scale by the cantilever spring constant and so
determine the slope Dz/Dx from Fig. 2.A typical bacteria stiffness in physiological solution
calculated from this equation is kb = 0.27 Nm
 1 shown by
the slope of control curve (x, untreated bacteria). The action
of PGLA is shown by curve4, which corresponds to a slope
of 0.013. The different slopes indicate that the stiffness of the
bacteria treated with PGLa decreased by a factor of 20 when
compared to the untreated bacteria curve; consequently, the
interaction of PGLa with E. coli resulted in a softer bacteria
surface. This reduction in cell stiffness on peptide treated
bacteria explains the poor resolution observed in the images
of bacteria treated with PGLa. The bacteria treated with
EDTA did not show any measurable difference in stiffness
(curve 5).
A surface stiffness variation off 5% was measured on
untreated bacteria. The reason for the small variation in the
force vs. separation curves is the substantially bigger stiff-
ness of the untreated bacteria when compared to the stiffness
of the cantilever. A different scenario is observed for PGLa
treated bacteria; experimentally determined error bars in the
force vs. separation curves for bacteria after PGLa treatment
are shown in Fig. 2.
3.4. EDTA action
Fig. 3 shows the action of EDTA (20 mM). Observe that
there is no substantial damage to the membrane (compare it
with the control). The effect of EDTA seems to be simply the
roughening of the outer membrane as shown in the inset of
Fig. 3. EDTA action on E. coli bacteria after the addition of EDTA (20 mM)
to the physiological solution (scanned area 4 4 Am2; inset area 11
Am2). Inset: amplification of the indicated area showing the roughness of
the bacterium top surface.
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in the literature, which claim that the chelating agent EDTA
removes Mg2 + ions from the lipopolysaccharide (LPS) layer
in the outer membrane of E. coli [15]. This ion cross-bridges
the negative charges of the LPS molecules eliminating
electrostatic repulsion and increasing molecular packing.
The observed roughness may be explained by an increase
in the area of the outer membrane or partial loss of LPS
molecules [16], which is confirmed by analysis of Fig. 3.
Bacteria retain their rod-shape morphology and rigidity as
shown in Fig. 2.
The chelating agent EDTA is known to increase the
permeability of the bacteria’s outer membrane by removing
divalent cations that neutralize the negative charges of lipid
A of LPS molecules. This results in the partial loss of LPS
molecules leading to an increase in the roughness of the
outer membrane without formation of holes or discontinu-
ities (Fig. 3). Treatment with EDTA during short periods is
not lethal to E. coli and may be used to introduce macro-
molecules through the outer membrane without significant
loss in bacteria viability [17,18]. The peptidoglycan wall is a
mechanically strong structure intrinsically involved in the
rigidity and morphology of bacteria. It also functions as a
barrier to large macromolecules such as peptides and
proteins [18], and does not seem to be damaged by EDTA
treatment alone. This is in accordance with our results which
demonstrate that E. coli retain its rigidity (Fig. 2) and
morphology (Fig. 3) during EDTA treatment.
3.5. AFM images scanned in air
In order to image the details of the peptide damage to
the bacteria structure at the bacteria/substrate interface,samples were observed on mica (surface free of f 20-
nm-diameter polylysine globules). Due to the low bacteria/
mica adhesion in liquid, samples were observed in air. The
other reason for observation of bacteria in air using AFM
is that it shows better resolution [16] than in water. The
morphology changes of bacteria were investigated by
observing cell deposited on mica, dried in ambient con-
ditions (21 jC, 40% humidity) and scanned in air. The
ruggosity variation at the top of the surface of the bacteria
submitted to the different treatments is probably the result
of the damage mainly to the outer membrane. An overview
of dried bacteria is depicted in Fig. 4. The typical rod-
shaped morphology of E. coli is clearly visible (Fig. 4a);
observe the large number of pili (f 30) [19] attached
to the bacteria body. The ruggosity at the top of the
surface of untreated bacteria shows an rms roughness of
f 1F 0.05 nm. Observe that the AFM image resolution in
the normal direction (z) to the scanned area isf 0.01 nm,
which results in a DRrmsc 0.05 nm. In order to further
examine the effects of the peptide PGLa (10 AM), various
treated bacteria samples were dried in air and then
scanned. Fig. 4b shows the action of PGLa. The outer
membrane was damaged, which is indicated by the pres-
ence of outer membrane residues at the edges of the cell
body (shown by arrows in Fig. 4b), probably due to
damage on the support structure that bound the outer
membrane to the cell wall and inner membrane. These
structures adhering to the substrate at the bacteria edge
were not removed by rinsing the sample with water after
the treatment with the peptide, indicating that they are not
any type of salt crystal. According to the image shown in
Fig. 1c, the outer membrane of PGLa treated bacteria tends
to remain attached to the substrate even after complete
lysis. Another important observation is the complete re-
moval of the piliar structure attached to the bacteria body
indicating that PGLa activity leads to the disruption of the
outer membrane. The ruggosity at the top of the surface of
PGLa treated bacteria increases substantially from 1 nm
(for untreated bacteria) tof 2.25F 0.03 nm, probably due
to the ruggose nature of the underlying peptidoglycan wall
that is exposed by the peptide treatment.
3.6. Effects of Mg2+ ions on PGLa activity
The molecular organization of the outer membrane of
bacteria involves the ion Mg2 + [9,17]. It has been previ-
ously shown that the antimicrobial peptides, like polymyx-
ins for example, have strong affinity to LPS and displace
Mg2 + from the outer membrane of bacteria [17,20]. To
further test this hypothesis, we investigated the effect of the
addition of 10 mM Mg2 + ions in the PGLa activity. The
effect is displayed in Fig. 5. The bacteria seem less
damaged, as confirmed by the analysis of the ruggosity at
its top surface. Peptide-treated bacteria in the presence of
Mg2 + showed an rms roughness of 1.7F 0.05 nm. This
value is smaller than the one measured for peptide treated
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Mg2 + had decreased the effect of PGLa, probably due to
competition for the negative charges present in LPS mole-
cules. The structures around the cell may possibly represent
outer membrane fragments that were not so easily washed
out by rinsing the sample with deionized water. It is
important to note, nevertheless, that drying is a complex
phenomenon and bacterial suspensions in culture mediumFig. 4. (a) Air-dried E. coli observed on mica. The cell surface is smooth
when compared to the image registered in the solution shown in Fig. 1
indicating that the drying process did not significantly alter the bacteria
surface morphology (scanned area 5 5 Am2; inset area 0.5 0.5 Am2). (b)
PGLa action on an E. coli bacterium after the addition of PGLa (10 AM) to
the physiological solution. After 5 min the sample was air-dried. The
roughness of the top surface of the cell increased substantially when
compared to the one shown in Fig. 2a. The arrows indicate part of the
bacterial outer membrane that remained attached to the substrate (scanned
area 3.5 3.5 Am2; inset area 0.5 0.5 Am2).
Fig. 5. E. coli in a physiological solution with 10 3 M MgCl2 then PGLa
was added to the solution. After 5 min the bacteria were removed from
the solution and then dried in air (scanned area 5 5 Am2; inset area
0.5 0.5 Am2).when dried on a substrate may produce artifactual structures
over the substrate.4. Discussion
4.1. AFM images analysis
The purpose of this work was to investigate the antimi-
crobial affect of PGLa against E. coli in physiological
solution and possibly raise some clues about the peptide
mechanism of action. The use of AFM allowed the direct
observation of living bacteria, without the drastic interfer-
ence induced by the steps involved in sample preparation for
electron microscopy analysis.
The AFM images shown in this work indicate that the
activity of the antimicrobial peptide has two stages. In the
first stage, as shown in Fig. 1b, PGLa damages the outer
membrane of E. coli causing the formation of micelles. This
type of activity in the outer membrane may be explained by
the carpet-like mechanism of action proposed for the per-
meabilization of membranes induced by antimicrobial pep-
tides of the magainin family [21]. The carpet-like mechanism
was first proposed to explain the activity of the antimicrobial
peptide dermaseptin S [22] and other natural analogues
[23,24]. It was also proposed for cecropins [25–27], caerin
1.1 [28], Trichogin GA IV [29], the human antimicrobial
peptide LL-37 [30] and many diastereomers of lytic peptides
[31–36].
The surface stiffness of PGLa treated bacteria, shown in
Fig. 2, has decreased by a factor of 20 when compared to
the one in untreated bacteria. These suggest that the outer
membrane and peptidoglycan wall structures are affected
by the action of the antimicrobial peptide. This is in
agreement with bacteria images in Fig. 1b that clearly
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later stage, there is cell rupture and loss of cytoplasm
material and only cell residual structures are observed
attached to the substrate (Fig. 1c). Our results then show
that the antimicrobial peptide PGLa seems to affect both
the outer membrane and peptidoglycan wall structures in
the early stage since the bacteria softened substantially after
5 min (Fig. 2). After 30 min the bacteria are completely
lysed (Fig. 1c) indicating that, after permeabilizing the
outer membrane and peptidoglycan wall structures, the
peptide also interferes with the inner membrane. In fact,
it has already been proposed that antimicrobial peptides of
the magainin family damage and permeabilize the inner
membrane of E. coli and this would be the cause of cell
death [37].
4.2. PGLa interaction mechanism
Gram-negative cell walls are among the most complex
enveloping structures in prokaryotic cells; they consist of
an outer membrane, which overlies a thin peptidoglycan
layer and a gel-like periplasm [12,38,39]. Although the
major stress-bearing structure in gram-negative cell walls is
thought to be the peptidoglycan layer, the outer membrane
has also been implicated and may be partially responsible
for shape, especially since outer membrane lipoproteins
can be strongly associated with the peptidoglycan layer
[40,41]. Consequently, the possible mechanism of interac-
tion of PGLa with the outer membrane and LPS is the
following: The outer membrane is a bilaminar structure
composed largely of LPS and phospholipids. Acidic phos-
phate groups are associated with the lipid A or inner core
components of the LPS. Mg2 + serves to stabilize the LPS,
and ultimately the outer membrane integrity, by bridging
adjacent LPS molecules through ionic association with
phosphate residues on the lipid A core [17]. The packing
of LPS molecules, which is essential for permeability
control and membrane integrity, depends on the ion
Mg2 +. If the PGLa peptide displaces Mg2 + from the
LPS, the peptide insertion into the bilayer would then
‘‘loosen’’ the outer membrane of bacteria [17]. This hy-
pothesis is supported by the results shown in Fig. 4b where
a probable loss of the outer membrane is observed, and in
Fig. 1 b which shows the formation of membrane origi-
nated micelles. The increase of the bacteria surface rough-
ness when compared to the surface of untreated bacteria
(Fig. 4a) may be explained by the fact that the peptido-
glycan wall is exposed (Fig. 4b). The residue of the outer
membrane remained attached to the substrate and is still
visible at the edge of the cell body (indicated by arrows in
Fig. 4b). The loosening of the outer membrane would be
explained by the reduction of LPS molecular packing as a
result of peptide insertion. This hypothesis is supported by
the fact that the peptide activity on the outer membrane
was inhibited by prior addition of Mg2 +. The higher yield
of Mg2 + probably inhibits the peptide activity by compe-tition, reducing the binding of the antimicrobial peptide
with LPS molecules and possibly with the peptidoglycan
wall. This is expected to result in higher molecular
packing, which is essential to the function of these struc-
tures as permeability barriers. Other evidence that corrob-
orates this model of activity is the function of the pagP
gene, which is responsible for the acylation of the lipid A
of the LPS of the bacteria Salmonella spp. reducing the
participation of Mg2 + in the outer membrane. This happens
in cases of Mg2 + or Ca2 + limitation and also leads to
Salmonella resistance to cationic antimicrobial peptides
[42]. It was also demonstrated that pagP mutants were
not able to develop resistance to the antimicrobial peptide
PGLa because the mutant cells were not able to acylate
lipid A [43]. The resistance arises from the fact that the
peptide cannot reach the inner membrane of the bacteria by
impairment of peptide uptake through the modified outer
membrane. The inner membrane permeabilization appears
to be the cause of bacterial death. Many hypotheses have
been presented to explain cell death, such as inner mem-
brane depolarization and impairment of energy production,
lipid disorganization and impairment of membrane func-
tions, formation of pores and leakage of cell components,
activation of programmed death through hydrolases and
interference with important intracellular processes after
peptide entry into the cytoplasm [44].
Our results also corroborate the self-promoted pathway
proposed to explain peptide entry into the bacterial cell [45].
This hypothesis is also in agreement with the fact that
heptose-deficient mutants of E. coli (deep-rough mutants)
present alterations in the LPS, which makes the outer mem-
brane of these bacteria unusually rough probably due to a
reduction in molecular packing. These bacteria also display
an increase in the permeability to a variety of molecules like
detergents, hydrophobic antibiotics, enzymes and DNA.
Interestingly, these mutants are more susceptible to EDTA
and its phenotype can be reversed by the addition of Mg2 +
[17].
In the second stage the PGLa interaction with E. coli
may also result in a structure that only shows bacterial
membrane residues. The residual structure indicated by
arrows has a height off 70 nm relative to the background
indicating that they are probably residual membrane struc-
tures attached to the substrate. The size of the residual
structure also corresponds to the size of the untreated
bacteria previously attached to the substrate. PGLa-treated
bacteria then show evidence of rupture and loss of cyto-
plasm in agreement with the previously described effects of
cell lysis, membrane blabbing and/or loss of cytoplasm
material, published in the literature and associated to the
action of antimicrobial peptides [46]. The loss of cytoplasm
material observed in Fig. 1c may be explained by the
interaction of PGLa with the inner membrane [37] after
permeabilization of the outer membrane and cell wall in the
first stage, as evident by cell softening (Fig. 2) and
formation of micelles (Fig. 1b).
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The PGLa-induced structural derangement includes the
loss of the surface stiffness of the bacteria and loss of the
outer membrane evident in the formation of micelles in the
images obtained in the culture medium and loss of pili and
the outer membrane in air dried samples. This action is in
accordance with the carpet-like mechanism for membrane
disruption proposed for peptides of the magainin family [21].
Our results also suggest that the PGLa peptide interacts
with the outer membrane by displacing Mg2 + from the LPS,
inserting itself into the bilayer and cross-binding the negative
charges of LPS lipids as proposed in the self promoted-
pathway [45]. This conclusion is reached since the treatment
with Mg2 + ions prior to peptide treatment partially inhibited
the effect of PGLa on bacteria. The evidence of the interac-
tion of PGLa with the inner membrane and cell wall comes
from the fact that the peptide action also resulted in cell
softening followed by cell rupture and loss of cytoplasmic
materials on a second stage. It is important to note that these
results were obtained by analyzing live bacteria in a culture
medium, avoiding artifacts produced by sample preparation
for conventional electron microscopy techniques.Acknowledgements
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